• Hired as the first commercialization employee, building the entire commercialization organizational structure including marketing, market access, operations, and sales while leading field force sizing and targeting exercises including HCPs and accounts.• Sustained accountability for UpRi launch readiness including brand development, strategic planning, and organizational development, initiating a cross-functional brand team to coordinate medical affairs, CMC, regulatory, legal, IT, and clinical development activities.• Directed launch forecasting effort for US and EU covering epidemiology, market share, and pricing assumptions as well as CDx testing and commercial supply forecasts.• Created a market access strategy inclusive of distribution and trade, payer, GPO contracting, pricing, and account management as well as hired a market access leader.• Established a CDx access and awareness strategy including sponsored testing, negotiated a commercialization agreement with CDx partner and several national reference labs, and hired and developed a diagnostic marketing role.

• Navigated roles of increasing responsibility across sales, operations, and marketing, focusing on growing market share of Zejula (brand name of Niraparib) for the treatment of epithelial ovarian, fallopian tube, and primary peritoneal cancer.• Served as a standing member of the Global Brand Strategy Team and Niraparib Clinical Development Team, stewarding the development of US Zejula brand strategy for HCP, patient, and payer, coordinating US launch across personal and digital channels, and managing P&L budget.• Directed the formulation of a new Zejula digital strategy that encompassed search, display, email, and sponsored programs that drove search interest and increased content engagement to an all-time high.• Spearheaded the development of Niraparib EU launch package in 2017, forming the basis of European launch readiness while creating global promotional platform, positioning, and message testing.• Crafted a commercial change initiative to strengthen execution and improve accountability, building business and coaching platforms that enabled East Areas to lead three sales teams in execution.

• Oversaw the US Sales team launch strategy for Ninlaro with a focus on demand, fulfillment, and adherence, building the pre-launch account profiling strategy, incentive compensation plan, and customer segmentation.• Established a commercial alliance with Novartis to co-promote Farydak, creating messaging, sales strategy, and co-promotion business rules to facilitate a successful partnership.• Conducted team building, recruiting, hiring, and training a group of 15 Clinical Nurse Educators from premier educational institutions to establish a high-quality and cohesive team.

• Led teams selling various medications to primary care physicians and specialists, providing coaching to employees to boost sales performance while collaborating with cross-functional stakeholders to analyze business trends, develop action plans, and convey necessary training.